Ignite Creation Date:
2024-05-06 @ 1:12 PM
Last Modification Date:
2024-10-26 @ 1:10 PM
Study NCT ID:
NCT03963323
Status:
COMPLETED
Last Update Posted:
2019-05-24
First Post:
2019-05-22
Brief Title:
Glucosamine and Chondroitin in Gut in Preventing People From Inflammation
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Study Overview
Official Title:
GLANCE21 - Glucosamine and Chondroitin GC Effects Study
Status:
COMPLETED
Status Verified Date:
2019-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial studies glucosamine and chondroitin in preventing inflammation Glucosamine and chondroitin often used as a dietary supplement to promote joint health may have a preventive role in inflammation and cancer This trial may help identify the bacteria that help process them in the gut
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 8645 | OTHER | FHCRC | None |